Infigratinib vs Pembrolizumab
Infigratinib vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Infigratinib and Pembrolizumab.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days.
Chemical Properties
Type: Infigratinib β Small molecule; Pembrolizumab β Antibody.